H5N1 News: Roche Increasing Tamiflu Production
An AP newswire article by Kevin Freking, via SFGate.com, reports that:
The manufacturer of a drug used to inhibit the effects of the bird flu virus will negotiate with generic drug companies to increase production, two U.S. senators announced Thursday.
Swiss-based Roche Holding AG will meet with four companies and maybe more in coming weeks, all in an effort to work out a licensing agreement that would allow other companies to produce Tamiflu, which is in great demand throughout the world.
"The bottleneck on Tamiflu has basically been broken," said Sen. Charles Schumer, D-N.Y., who announced the agreement along with Sen. Lindsey Graham, R-S.C.
The two senators met with George Abercrombie, head of Roche Pharmaceuticals in North America.
0 Comments:
Post a Comment
<< Home